Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Pharmacotherapy. 2017 Sep;37(9):988-989. doi: 10.1002/phar.1975. Epub 2017 Aug 7.
The topic of precision medicine is increasingly more prevalent in the general medical literature, with oncology research leading the way. Many factors, such as availability of targeted drugs, advances in laboratory science, and improved information systems, converged to make precision medicine research possible on a large scale at the National Cancer Institute. The resultant big data will spur new kinds of research in the decades to come, but until then, all clinicians are challenged to make sense of an overabundance of information when managing individual patients.
精准医学的话题在一般医学文献中越来越流行,肿瘤学研究走在前列。许多因素,如靶向药物的可及性、实验室科学的进步和信息系统的改善,汇聚在一起,使大规模的精准医学研究成为可能。国家癌症研究所。由此产生的大数据将在未来几十年推动新的研究,但在此之前,所有临床医生都面临着在管理个体患者时应对过多信息的挑战。